View Document Preview and Link Document Date: 2013-03-10 18:26:15 Open Document File Size: 65,17 KB Share Result on Facebook
City Vancouver / / Company Accident Compensation Corporation / Ramelet A.S. / Mepitel / Medline / SurfaSoft / Google / / Country France / / Currency USD / / Facility Stable Vitiligo / The Cochrane Library / / IndustryTerm age groups / clinical protocol / chemical peeling / autologous cell harvesting device / experimental / chemical peels / control / possible future applications / autologous cell-harvesting device / / MedicalCondition mild infection / scar / TB / burn / disease / PlaceboControlled Study Vitiligo A / congenital skin dysfunction / hypopigmentation / congenital melanocytic nevus / pain / injury / Stable Vitiligo / autoimmune disease / large congenital melanocytic nevus / burns / preliminary report Vitiligo / pilot study Condition/Detail Vitiligo / Vitiligo / non-segmental Vitiligo / Vitiligo Vitiligo / / MedicalTreatment laser therapy / dermabrasion / clinical protocol / skin grafts / chemical peels / phototherapy / / Organization Therapeutic Goods Administration / FDA / / Person Natalie Hardaker / Al Eisa / Al Issa / / Position plastic surgeon / surgeon / official view / / Product ReCell suspension / Accident Compensation Corporation Suspensions / ReCell / / ProvinceOrState Western Australia / / PublishedMedium British Journal of Dermatology / / Region Western Australia / / Technology laser / clinical protocol / transplantation / / SocialTag 
Brief Report The ReCell system; Clinical application and efficacy for use Reviewer Natalie Hardaker